Dr. Uzma Rahat, M.D

NPI: 1811180235
Total Payments
$181.87
2024 Payments
$46.65
Companies
5
Transactions
6
Medicare Patients
707
Medicare Billing
$58,503

Payment Breakdown by Category

Food & Beverage$181.87 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $181.87 6 100.0%

Top Paying Companies

Company Total Records Latest Year
Horizon Therapeutics plc $106.34 1 $0 (2022)
Janssen Pharmaceuticals, Inc $28.88 2 $0 (2018)
AstraZeneca Pharmaceuticals LP $16.39 1 $0 (2024)
Amgen Inc. $15.23 1 $0 (2024)
Novo Nordisk Inc $15.03 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $46.65 3 AstraZeneca Pharmaceuticals LP ($16.39)
2022 $106.34 1 Horizon Therapeutics plc ($106.34)
2018 $14.29 1 Janssen Pharmaceuticals, Inc ($14.29)
2017 $14.59 1 Janssen Pharmaceuticals, Inc ($14.59)

All Payment Transactions

6 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/17/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $15.23 General
Category: Inflammation
08/13/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $16.39 General
Category: Respiratory
02/08/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $15.03 General
Category: Diabetes
05/17/2022 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $106.34 General
Category: KRYSTEXXA
03/01/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.29 General
Category: Cardiovascular & Metabolism
12/04/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.59 General
Category: Cardiovascular & Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 451 749 $114,421 $34,591
2022 8 256 432 $76,125 $23,912
Total Patients
707
Total Services
1,181
Medicare Billing
$58,503
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 115 183 $55,500 $16,559 29.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 126 155 $32,939 $9,552 29.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 39 39 $11,945 $5,077 42.5%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 30 36 $4,983 $1,075 21.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 13 13 $5,225 $1,066 20.4%
96372 Injection of drug or substance under skin or into muscle Office 2023 42 60 $2,058 $631.15 30.7%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 24 24 $943.95 $442.60 46.9%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 22 116 $464.00 $93.45 20.1%
81000 Manual urinalysis test with examination using microscope, non-automated Office 2023 13 13 $143.00 $51.22 35.8%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2023 27 110 $220.00 $43.92 20.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 85 132 $43,296 $13,445 31.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 63 71 $16,472 $5,069 30.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 20 20 $6,700 $2,645 39.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 13 13 $5,525 $1,624 29.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 16 16 $2,288 $576.81 25.2%
96372 Injection of drug or substance under skin or into muscle Office 2022 27 40 $1,440 $464.20 32.2%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2022 12 62 $248.00 $57.07 23.0%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2022 20 78 $156.00 $31.13 20.0%

About Dr. Uzma Rahat, M.D

Dr. Uzma Rahat, M.D is a Internal Medicine healthcare provider based in West Columbia, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1811180235.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Uzma Rahat, M.D has received a total of $181.87 in payments from pharmaceutical and medical device companies, with $46.65 received in 2024. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($181.87).

As a Medicare-enrolled provider, Rahat has provided services to 707 Medicare beneficiaries, totaling 1,181 services with total Medicare billing of $58,503. Data is available for 2 years (2022–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Geriatric Medicine
  • Location West Columbia, TX
  • Active Since 08/20/2007
  • Last Updated 03/30/2023
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1811180235

Products in Payments

  • KRYSTEXXA (Biological) $106.34
  • XARELTO (Drug) $28.88
  • AIRSUPRA (Drug) $16.39
  • TAVNEOS (Drug) $15.23
  • Rybelsus (Drug) $15.03

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in West Columbia